 role new antiplatelet agent adjunct therapi thrombolysi coronari thrombolysi treatment choic patient acut q-wave myocardi infarct contraind therapi time thrombolysi possibl reocclus infarct-rel arteri remain problemat herein experiment anim studi clinic evalu attempt adjunct therapi avail thrombolyt intervent time thrombolysi delay prevent reocclus studi date clear combin thromboxan synthesi inhibitor receptor antagonist serotonin receptor antagonist heparin time thrombolysi delay prevent coronari arteri reocclus experiment canin model copper coil-induc coronari arteri thrombi monoclon antibodi platelet glycoprotein iib/iiia receptor tissu plasminogen activ t-pa heparin time thrombolysi delay prevent reocclus experiment canin model thrombin inhibitor heparin synthet inhibitor t-pa aspirin time thrombolysi delay prevent coronari arteri reocclus experiment canin model aspirin intraven streptokinas reduc mortal patient presum acut myocardi infarct combin heparin t-pa result infarct-arteri patenc t-pa heparin data studi regard possibl effect safe thrombolyt regimen time thrombolysi delay prevent coronari arteri reocclus